Dr Gary Newton is a medicinal chemist and project leader with over 15 years’ experience in biotech and related industries. He has extensive experience working on a range of targets in all phases from hit identification through to pre-clinical candidate nomination. During his time at Domainex Gary has been the principal architect of the design of three candidate drugs, and managed collaborations with Domainex’s strategic partners. Prior to joining Domainex Gary worked for OSI Pharmaceuticals in oncology on several different programmes and was an integral member of the team that produced a candidate drug for their c-kit/KDR programme.
Gary obtained his PhD from the University of Sheffield in 2000 where he investigated asymmetric routes to the synthesis of tropane alkaloids with Prof. Varinder Aggarwal.